Caribou Bio’s Journey With Off-the-Shelf Cell Therapy Reaches the End of the Road
Caribou Biosciences is stopping work on its two remaining most cancers cell therapies and exploring strategic options for the enterprise. ...
Tag: Bios
Braveheart Bio’s $382M IPO for Heart Drug Leads a Big Week for Biotech IPOs
One takeaway from this 12 months’s surge of biotech IPO exercise is that traders need to see at the least ...
Gates Foundation Joins Radiant Bio’s $35M Round for Antibody Drugs With ‘Better Grip’
An antibody drug is only as good as its ability to connect to its target. Sometimes a mutation at the ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!